News
Shortcuts from other journals
Aprotinin linked to excess deaths after coronary artery surgery
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7589.336-b (Published 15 February 2007) Cite this as: BMJ 2007;334:336
Last year 246 000 Americans received aprotinin during coronary artery surgery. Aprotinin reduces bleeding and has been licensed for use during coronary artery surgery since 1993 in the United States. More recently, aprotinin has been linked to renal toxicity; cardiovascular, cerebrovascular, and pulmonary vascular …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.